blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1461758

EP1461758 - CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2 AND BINDING POCKETS THEREOF [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  25.11.2005
Database last updated on 05.10.2024
Most recent event   Tooltip25.07.2008Change - representativepublished on 27.08.2008  [2008/35]
Applicant(s)For all designated states
VERTEX PHARMACEUTICALS INCORPORATED
130 Waverly Street
Cambridge, MA 02139-4242 / US
[2004/40]
Inventor(s)01 / MENG, Wuyi
19 Crestview Drive
Westborough, MA 01581 / US
02 / SWENSON, Lovorka
5 Davis Road
Belmont, MA 02478 / US
 [2004/40]
Representative(s)Vossius & Partner Patentanwälte Rechtsanwälte mbB
Siebertstrasse 3
81675 München / DE
[N/P]
Former [2008/35]Vossius & Partner
Siebertstrasse 3
81675 München / DE
Former [2004/40]VOSSIUS & PARTNER
Siebertstrasse 4
81675 München / DE
Application number, filing date02799215.505.12.2002
[2004/40]
WO2002US39070
Priority number, dateUS20010337513P05.12.2001         Original published format: US 337513 P
[2004/40]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03048340
Date:12.06.2003
Language:EN
[2003/24]
Type: A2 Application without search report 
No.:EP1461758
Date:29.09.2004
Language:EN
The application published by WIPO in one of the EPO official languages on 12.06.2003 takes the place of the publication of the European patent application.
[2004/40]
Search report(s)International search report - published on:US30.10.2003
(Supplementary) European search report - dispatched on:EP19.08.2005
ClassificationIPC:G06G7/48, G06G7/58, G01N33/48, G01N33/50, A61K39/00
[2004/40]
CPC:
C12N9/1205 (EP,US); C12Q1/485 (EP,US); G01N33/573 (EP,US);
G16B15/30 (EP,US); C07K2299/00 (EP,US); G16B15/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   SI,   SK,   TR [2004/40]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
TitleGerman:KRISTALLSTRUKTUR EINES MITOGENAKTIVIERTEN PROTEINS, KINASE-AKTIVIERTES PROTEIN, KINASE-2 UND BINDE-POCKETS DAFÜR[2004/40]
English:CRYSTAL STRUCTURE OF MITOGEN-ACTIVATED PROTEIN KINASE-ACTIVATED PROTEIN KINASE 2 AND BINDING POCKETS THEREOF[2004/40]
French:STRUCTURE CRISTALLINE DE PROTEINE KINASE 2 ACTIVEE PAR LA PROTEINE KINASE ACTIVEE PAR DES AGENTS MITOGENES ET POCHES DE FIXATION[2004/40]
Entry into regional phase05.07.2004National basic fee paid 
05.07.2004Search fee paid 
05.07.2004Designation fee(s) paid 
05.07.2004Examination fee paid 
Examination procedure30.06.2003Request for preliminary examination filed
International Preliminary Examining Authority: US
05.07.2004Examination requested  [2004/40]
16.11.2005Application withdrawn by applicant  [2006/02]
Fees paidRenewal fee
31.12.2004Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[PX]WO02090524  (MERCK & CO INC [US], et al) [PX] 1-14 * the whole document *;
 [A]  - WILSON K P ET AL, "Crystal structure of p38 mitogen-activated protein kinase.", THE JOURNAL OF BIOLOGICAL CHEMISTRY. 1 NOV 1996, (19961101), vol. 271, no. 44, ISSN 0021-9258, pages 27696 - 27700, XP002339160 [A] 1-16,20-30 * the whole document *

DOI:   http://dx.doi.org/10.1074/jbc.271.44.27696
 [A]  - GSCHWEND D A ET AL, "MOLECULAR DOCKING TOWARDS DRUG DISCOVERY", JOURNAL OF MOLECULAR RECOGNITION, HEYDEN & SON LTD., LONDON, GB, (1996), vol. 9, ISSN 0952-3499, pages 175 - 186, XP000882526 [A] 1-16,20-30 * the whole document *

DOI:   http://dx.doi.org/10.1002/(SICI)1099-1352(199603)9:2<175::AID-JMR260>3.0.CO;2-D
International search[XP]  - MENG W.M. ET AL., "Structure of mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 suggests a bifunctional switch that couples kinase activation with nuclear export", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (200210), vol. 277, no. 40, pages 37401 - 37405, XP002965434

DOI:   http://dx.doi.org/10.1074/jbc.C200418200
 [XP]  - "Crystal structure of mapkap2", PROTEIN DATA BANK RECORD, (20020918), URL: http://www.rcsb.org/pdb/., XP002965438
 [Y]  - HOLLAND P.M. ET AL., "Protein modification: docking sites for kinases", CURRENT BIOLOGY, (1999), vol. 9, pages R329 - R331, XP002965435

DOI:   http://dx.doi.org/10.1016/S0960-9822(99)80205-X
 [Y]  - ENGEL K. ET AL., "Constitutive activation of mitogen-activated protein kinase-activated protein kinase 2 by mutation of phosphorylation sites and an A-helix motif", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (199511), vol. 270, no. 45, pages 27213 - 27221, XP002226892

DOI:   http://dx.doi.org/10.1074/jbc.270.40.23790
 [Y]  - ZU Y.-L. ET AL., "Characterization of an autoinhibitory domain in human mitogen activated protein kinase activated protein kinase 2", THE JOURNAL OF BIOLOGICAL CHEMISTRY, (199501), vol. 270, no. 1, pages 202 - 206, XP002965436

DOI:   http://dx.doi.org/10.1074/jbc.270.1.202
 [Y]  - PEARSON G. ET AL., "Mitogen activated protein (MAP) kinase pathways: regulation and physiological functions", ENDOCRINE REVIEWS, (2001), vol. 22, no. 2, pages 153 - 183, XP002235969

DOI:   http://dx.doi.org/10.1210/er.22.2.153
 [A]  - NEW L. ET AL., "The p38 map kinase pathway and its biological function", TRENDS IN CARDIOVASCULAR MEDICINE, (199807), vol. 8, no. 5, pages 220 - 228, XP002965437

DOI:   http://dx.doi.org/10.1016/S1050-1738(98)00012-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.